Mark Smit - BioRem Director Services
| BRM Stock | CAD 3.00 0.02 0.67% |
Insider
Mark Smit is Director Services of BioRem Inc
| Address | 7496 Wellington Road 34, Puslinch, ON, Canada, N0B 2J0 |
| Phone | 519 767 9100 |
| Web | https://www.biorem.biz |
BioRem Management Efficiency
The company has return on total asset (ROA) of 0.1461 % which means that it generated a profit of $0.1461 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5968 %, meaning that it generated $0.5968 on every $100 dollars invested by stockholders. BioRem's management efficiency ratios could be used to measure how well BioRem manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.1 in 2024. Return On Capital Employed is likely to climb to 0.32 in 2024. At this time, BioRem's Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 3.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.9 M in 2024.Similar Executives
| Found 11 records | INSIDER Age | ||
| Deborah Weinstein | Thermal Energy International | 64 | |
| Lewis Smith | CHAR Technologies | N/A | |
| CPA CFA | CHAR Technologies | 60 | |
| Andy PEng | BluMetric Environmental | N/A | |
| Silvia Merlini | CHAR Technologies | N/A | |
| MEng MBA | Thermal Energy International | N/A | |
| Don Kirk | CHAR Technologies | N/A | |
| Andrew White | CHAR Technologies | N/A | |
| Vince Sands | Thermal Energy International | N/A | |
| Robert Triebe | Thermal Energy International | N/A | |
| Darcy MBA | Vitreous Glass | N/A | |
Management Performance
BioRem Inc Leadership Team
Elected by the shareholders, the BioRem's board of directors comprises two types of representatives: BioRem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioRem. The board's role is to monitor BioRem's management team and ensure that shareholders' interests are well served. BioRem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioRem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dan Costello, Director Operations | ||
| PEng MBA, President CEO | ||
| Mark Smit, Director Services | ||
| Douglas Newman, CFO, Secretary |
BioRem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioRem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.6 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 45.12 M | ||||
| Shares Outstanding | 15.8 M | ||||
| Shares Owned By Insiders | 1.90 % | ||||
| Shares Owned By Institutions | 0.44 % | ||||
| Number Of Shares Shorted | 2.67 K | ||||
| Price To Earning | 3.01 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.